Estée Lauder (EL) is trading higher as markets continue to digest its May 1, 2026 fiscal third-quarter update, where management raised full-year fiscal 2026 outlook metrics tied to organic net sales and adjusted profitability. The move is being reinforced by a wave of post-results analyst actions over the past day, with several firms lifting price targets—helping keep incremental buyers engaged after the initial earnings reaction.

In its May 1 release, Estée Lauder raised its full-year fiscal 2026 outlook for organic net sales and adjusted profitability and also provided a preliminary view for fiscal 2027, which investors are treating as an early sign the company’s recovery plan is gaining traction. The company also reiterated capital-return continuity by declaring a quarterly dividend payable June 15, 2026 (record date May 29, 2026), which can further support sentiment in a volatile tape. (nasdaq.com)

Analyst updates in the last 24–48 hours have contributed to the upside. UBS raised its price target after the earnings beat and guidance lift, pointing to improved organic sales assumptions and margin dynamics embedded in the updated outlook. Barclays also lifted its price target (while keeping an Equalweight stance), citing progress in the restructuring path as the market reassesses near-term execution risk. (uk.investing.com)

Key questions for the next leg higher are whether Estée Lauder can turn a margin-led rebound into durable, mid-single-digit sales growth and whether travel retail and China trends stabilize enough to support the company’s longer-dated expectations. Investors will also watch restructuring execution and any incremental commentary on fiscal 2027 as the company moves from “raise guidance” headlines to quarter-by-quarter proof of demand and share gains. (nasdaq.com)